Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS

被引:1
|
作者
Lopez-Chiriboga, Sebastian [1 ]
Pittock, Sean J. [1 ,2 ]
Weinshenker, Brian G. [1 ]
Chen, John J. [1 ,3 ]
Flanagan, Eoin [1 ,2 ]
机构
[1] Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med & Pathol, 200 1st St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Ophthalmol, 200 1st St SW, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.msard.2019.06.037
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:34 / 35
页数:2
相关论文
共 50 条
  • [31] Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
    Das, Shambaditya
    Pandit, Alak
    Ray, Biman Kanti
    Dubey, Souvik
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2023, 59 (01):
  • [32] Predictors of Conversion from Positive to Negative Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Status
    Hayman, Adeline
    Vishnevetsky, Anastasia
    Romanow, Gabriela
    Levy, Michael
    NEUROLOGY, 2023, 100 (17)
  • [33] Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses
    Epstein, Samantha E.
    Levin, Seth
    Onomichi, Kaho
    Langston, Christopher
    Yeshokumar, Anusha
    Fabian, Michelle
    Sand, Ilana Katz
    Klineova, Sylvia
    Lublin, Fred
    Dykstra, Kiersten
    Xia, Zongqi
    De Jager, Philip
    Levine, Libby
    Farber, Rebecca
    Riley, Claire
    Vargas, Wendy S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [34] Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
    Shambaditya Das
    Alak Pandit
    Biman Kanti Ray
    Souvik Dubey
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 59
  • [35] Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Mediated Disease: The Difficulty of Predicting Relapses
    Epstein, S.
    Levin, S. N.
    Onomichi, K.
    Langston, C.
    Yeshokumar, A.
    Dykstra, K.
    Xia, Z.
    Levine, L.
    De Jager, P. L.
    Farber, R.
    Riley, C. S.
    Vargas, W. S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (1_SUPPL) : 82 - 82
  • [36] Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
    Pujari, Shripad S.
    Kulkarni, Rahul V.
    Nadgir, Dattatraya B.
    Ojha, Pawan K.
    Nagendra, Shashank
    Aglave, Vikram
    Nadgir, Rashmi D.
    Sant, Hemant
    Palasdeokar, Nilesh
    Nirhale, Satish
    Bandishti, Sunil
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2021, 24 (01) : 69 - 77
  • [37] Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid (vol 271, pg 2662, 2024)
    Burton, Jodie M.
    Youn, Saerom
    Al-Ani, Abdullah
    Costello, Fiona
    JOURNAL OF NEUROLOGY, 2024, 271 (08) : 5708 - 5711
  • [38] Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity-a potential diagnostic pitfall in patients with MOG-EM/MOGAD
    Jarius, S.
    Ringelstein, M.
    Schanda, K.
    Ruprecht, K.
    Korporal-Kuhnke, M.
    Viehoever, A.
    Huemmert, M. W.
    Schindler, P.
    Endmayr, V.
    Gastaldi, M.
    Trebst, C.
    Franciotta, D.
    Aktas, O.
    Hoeftberger, R.
    Haas, J.
    Komorowski, L.
    Paul, F.
    Reindl, M.
    Wildemann, B.
    JOURNAL OF NEUROLOGY, 2024, 271 (07) : 4660 - 4671
  • [39] Association of the T-cell reactivity to myelin oligodendrocyte glycoprotein (MOG) with disease activity in MS
    Milo, R
    de Rosbo, NK
    Mendel, I
    Nadiv, O
    Flechter, S
    Rabey, JM
    Ben-Nun, A
    NEUROLOGY, 1998, 50 (04) : A152 - A152
  • [40] Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis
    Nepal, Gaurav
    Kharel, Sanjeev
    Coghlan, Megan Ariel
    Rayamajhi, Parash
    Ojha, Rajeev
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 364